Myoglobin over-expression attenuates angiogenic response in hindlimb ischemia in mice

Chinese Medical Journal

Volumn 122, Issue 9, 2009, Pages 1056-1060

  Yang, Yao Guo ^a   Guan, Heng ^a   Liu, Chang Wei ^a   Li, Yong Jun ^a  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

Author keywords

Angiogenic; Ischemia; Myoglobin; Nitric oxide

Indexed keywords

CYCLINE; MYOGLOBIN; NITRIC OXIDE; PHOSPHATE; PROTEIN BAX; PROTEIN BCL 2; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GASTROCNEMIUS MUSCLE; HISTOPATHOLOGY; LASER DOPPLER FLOWMETRY; LEG ISCHEMIA; MOUSE; NONHUMAN; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; TIBIALIS ANTERIOR MUSCLE; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CELL PROLIFERATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; HINDLIMB; IMMUNOHISTOCHEMISTRY; ISCHEMIA; MICE; MICE, TRANSGENIC; MUSCLE, SKELETAL; MYOGLOBIN;

EID: 68149182735     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2009.09.009     Document Type: Article

References (15)

1. Ordway GA, Garry DJ. Myoglobin: an essential hemoprotein in striated muscle. J Exp Biol 2004; 207(Pt 20): 3441-3446.
2. Hankey GJ, Norman PE, Eikelboom JW. Medical treatment of peripheral arterial disease. JAMA 2006; 295: 547-553.
3. Schainfeld RM, Isner JM. Critical limb ischemia: nothing to give at the office? Ann Intern Med 1999; 130: 442-444.
4. Folkman J. Seminars in medicine of the Beth Israel Hospital, Boston: clinical applications of research on angiogenesis. N Engl J Med 1995; 333: 1757-1763.
5. Isner JM. Therapeutic angiogenesis: a new frontier for vascular therapy. Vasc Med 1996; 1: 79-87.
6. Xie D, Li Y, Reed EA, Odronic SI, Kontos CD, Annex BH. An engineered vascular endothelial growth factor-activating transcription factor induces therapeutic angiogenesis in ApoE knockout mice with hindlimb ischemia. J Vasc Surg 2006; 44: 165-175.
7. Simons M. Angiogenesis: where do we stand now? Circulation 2005; 111: 1556-1566.
8. Ziche M, Morbidelli L, Masini E, Amerini S, Granger HJ, Maggi CA, et al. Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vitro promoted by substance P. J Clin Invest 1994; 94: 2036-2044.
9. Murohara T, Asahara T, Silver M, Bauters C, Masuda H, Kalka C, et al. Nitric oxide synthase modulates angiogenesis in response to tissue ischemia. J Clin Invest 1998; 101: 2567-2578.
10. Brunori M. Nitric oxide, cytochrome-c oxidase and myoglobin. Trends Biochem Sci 2001; 26: 21-23.
11. Mammen PP, Kanatous SB, Yuhanna IS, Shaul PW, Garry MG, Balaban RS, et al. Hypoxia-induced left ventricular dysfunction in myoglobin-deficient mice. Am J Physiol Heart Circ Physiol 2003; 285: H2132- H2141.
12. Couffinhal T, Silver M, Zheng LP, Kearney M, Witzenbichler B, Isner JM. Mouse model of angiogenesis. Am J Pathol 1998; 152: 1667-1679.
13. Li Y, Hazarika S, Xie D, Pippen AM, Kontos CD, Annex BH. In mice with type diabetes, a vascular endothelial growth factor (VEGF)-activating transcription factor modulates VEGF signaling and induces therapeutic angiogenesis after hindlimb ischemia. Diabetes 2007; 56: 656-665.
14. Hood J, Granger HJ. Protein kinase G mediates vascular endothelial growth factor-induced Raf-1 activation and proliferation in human endothelial cells. J Biol Chem 1998; 273: 23504-23508.
15. Li WJ, Zhao ZJ, Liu B, Zhang DX, Li F, Wang HC, et al. Nitric oxide induced heat shock protein 72 production and delayed protection against myocardial ischemia in rabbits via activating protein kinase C. Chin Med J 2008; 121: 1109-1113.